Discontinued — last reported Q2 '20
Biogen Change in Income Taxes Payable increased by 108.0% to $18.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 73.4%, from $69.10M to $18.40M.
An increase indicates deferred cash outflows for taxes, while a decrease indicates the settlement of tax liabilities.
Represents the net change in the amount of income tax owed to government authorities that has not yet been settled in ca...
Standard line item in the operating section of the cash flow statement for all tax-paying corporations.
cvx_change_in_income_taxes_payable| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $106.70M | $89.00M | $101.90M | -$167.80M | -$34.30M | $65.00M | -$147.40M | -$32.40M | -$2.20M | -$5.50M | $69.80M | $69.10M | -$603.80M | -$229.40M | $18.40M |
| QoQ Change | — | -16.6% | +14.5% | -264.7% | +79.6% | +289.5% | -326.8% | +78.0% | +93.2% | -150.0% | >999% | -1.0% | -973.8% | +62.0% | +108.0% |
| YoY Change | — | — | — | -257.3% | -138.5% | -36.2% | +12.2% | +5.5% | -103.4% | +96.3% | +315.4% | >999% | <-999% | -428.7% | -73.4% |